In addition, the combination of iDCs with ICI and radiotherapy may achieve potent synergistic anti-tumor effects better than single-agent treatments, characterized by increased infiltration of CD8 T cells or NK cells into solid tumors, enhancing the overall immune response against cancer [67, 68]. Here, CD8A is linked to neoplasm.